Hypermarcas (OTCMKTS:HYPMY) Reaches New 52-Week High – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY)’s stock price reached a new 52-week high during trading on Thursday . The stock traded as high as $5.32 and last traded at $5.32, with a volume of 1086 shares traded. The stock had previously closed at $4.9850.

Hypermarcas Stock Performance

The company’s 50-day simple moving average is $4.52 and its 200-day simple moving average is $4.44. The stock has a market capitalization of $3.37 billion, a price-to-earnings ratio of 23.13 and a beta of 0.72. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings data on Wednesday, November 12th. The company reported $0.13 earnings per share for the quarter. The company had revenue of $408.83 million for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.